Diabetes Drug Wins in HFrEF; Swift Shift to TAVR; Neurologists to Tackle HTN? - MedPage Today

Diabetes Drug Wins in HFrEF; Swift Shift to TAVR; Neurologists to Tackle HTN?  MedPage Today

The SGLT2 diabetes drug dapagliflozin (Farxiga) significantly reduced cardiovascular death and worsening of heart failure with reduced ejection fraction in ...